ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chronic Venous Insufficiency Market Research Report 2026
Published Date: 2026-02-27
|
Report Code: QYRE-Auto-17R18424
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Chronic Venous Insufficiency Market Research Report 2024
BUY CHAPTERS

Global Chronic Venous Insufficiency Market Research Report 2026

Code: QYRE-Auto-17R18424
Report
2026-02-27
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shanghai Lanmai Medical Technology
Hangzhou Weiqiang Medical Technology
Suzhou Yinluo Medical Devices
Zylox-Tonbridge Medical Technology
Shanghai Ensheng Medical Technology
Suzhou Tianhong Shengjie Medical Devices
BD(Angiomed)
Boston Scientific
Cook Ireland
Medtronic Inc
OptiMed Medizinische Instrumente
Philips
3M
TEVA
Mylan NV
Pfizer Inc
AbbVie
Abbott
Allergan plc
Sun Pharma

Chronic Venous Insufficiency Market

The global Chronic Venous Insufficiency market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Chronic venous insufficiency (CVI) is a common progressive disease that affects the superficial and deep venous systems of the lower extremities. CVI is characterized by valvular insufficiency, reflux, venous obstruction, or a combination, leading to distal venous hypertension. Clinical manifestations of CVI include edema, pain, skin changes, ulcers, and dilated cutaneous veins of the lower extremities.
The North American market for Chronic Venous Insufficiency is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Chronic Venous Insufficiency is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for Chronic Venous Insufficiency in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of Chronic Venous Insufficiency include Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Chronic Venous Insufficiency market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Chronic Venous Insufficiency. The Chronic Venous Insufficiency market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Chronic Venous Insufficiency market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Chronic Venous Insufficiency manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Chronic Venous Insufficiency Market Report

Report Metric Details
Report Name Chronic Venous Insufficiency Market
Segment by Type
  • Medical Equipment and Consumables
  • Drugs
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, optimed Medizinische Instrumente, Philips, 3M, Teva, Mylan, Pfizer, AbbVie, Abbott, Allergan, Sun Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Chronic Venous Insufficiency companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Venous Insufficiency Market report?

Ans: The main players in the Chronic Venous Insufficiency Market are Shanghai Lanmai Medical Technology, Hangzhou Weiqiang Medical Technology, Suzhou Yinluo Medical Devices, Zylox-Tonbridge Medical Technology, Shanghai Ensheng Medical Technology, Suzhou Tianhong Shengjie Medical Devices, BD(Angiomed), Boston Scientific, Cook Ireland, Medtronic, optimed Medizinische Instrumente, Philips, 3M, Teva, Mylan, Pfizer, AbbVie, Abbott, Allergan, Sun Pharma

What are the Application segmentation covered in the Chronic Venous Insufficiency Market report?

Ans: The Applications covered in the Chronic Venous Insufficiency Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Chronic Venous Insufficiency Market report?

Ans: The Types covered in the Chronic Venous Insufficiency Market report are Medical Equipment and Consumables, Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Venous Insufficiency Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Medical Equipment and Consumables
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global Chronic Venous Insufficiency Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Venous Insufficiency Market Perspective (2021–2032)
2.2 Global Chronic Venous Insufficiency Growth Trends by Region
2.2.1 Global Chronic Venous Insufficiency Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Chronic Venous Insufficiency Historic Market Size by Region (2021–2026)
2.2.3 Chronic Venous Insufficiency Forecasted Market Size by Region (2027–2032)
2.3 Chronic Venous Insufficiency Market Dynamics
2.3.1 Chronic Venous Insufficiency Industry Trends
2.3.2 Chronic Venous Insufficiency Market Drivers
2.3.3 Chronic Venous Insufficiency Market Challenges
2.3.4 Chronic Venous Insufficiency Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Venous Insufficiency Players by Revenue
3.1.1 Global Top Chronic Venous Insufficiency Players by Revenue (2021–2026)
3.1.2 Global Chronic Venous Insufficiency Revenue Market Share by Players (2021–2026)
3.2 Global Top Chronic Venous Insufficiency Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Chronic Venous Insufficiency Revenue
3.4 Global Chronic Venous Insufficiency Market Concentration Ratio
3.4.1 Global Chronic Venous Insufficiency Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Venous Insufficiency Revenue in 2025
3.5 Global Key Players of Chronic Venous Insufficiency Head Offices and Areas Served
3.6 Global Key Players of Chronic Venous Insufficiency, Products and Applications
3.7 Global Key Players of Chronic Venous Insufficiency, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Chronic Venous Insufficiency Breakdown Data by Type
4.1 Global Chronic Venous Insufficiency Historic Market Size by Type (2021–2026)
4.2 Global Chronic Venous Insufficiency Forecasted Market Size by Type (2027–2032)
5 Chronic Venous Insufficiency Breakdown Data by Application
5.1 Global Chronic Venous Insufficiency Historic Market Size by Application (2021–2026)
5.2 Global Chronic Venous Insufficiency Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Chronic Venous Insufficiency Market Size (2021–2032)
6.2 North America Chronic Venous Insufficiency Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Chronic Venous Insufficiency Market Size by Country (2021–2026)
6.4 North America Chronic Venous Insufficiency Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Venous Insufficiency Market Size (2021–2032)
7.2 Europe Chronic Venous Insufficiency Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Chronic Venous Insufficiency Market Size by Country (2021–2026)
7.4 Europe Chronic Venous Insufficiency Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Chronic Venous Insufficiency Market Size (2021–2032)
8.2 Asia-Pacific Chronic Venous Insufficiency Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Chronic Venous Insufficiency Market Size by Region (2021–2026)
8.4 Asia-Pacific Chronic Venous Insufficiency Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Chronic Venous Insufficiency Market Size (2021–2032)
9.2 Latin America Chronic Venous Insufficiency Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Chronic Venous Insufficiency Market Size by Country (2021–2026)
9.4 Latin America Chronic Venous Insufficiency Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Venous Insufficiency Market Size (2021–2032)
10.2 Middle East & Africa Chronic Venous Insufficiency Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2021–2026)
10.4 Middle East & Africa Chronic Venous Insufficiency Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Lanmai Medical Technology
11.1.1 Shanghai Lanmai Medical Technology Company Details
11.1.2 Shanghai Lanmai Medical Technology Business Overview
11.1.3 Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Introduction
11.1.4 Shanghai Lanmai Medical Technology Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.1.5 Shanghai Lanmai Medical Technology Recent Development
11.2 Hangzhou Weiqiang Medical Technology
11.2.1 Hangzhou Weiqiang Medical Technology Company Details
11.2.2 Hangzhou Weiqiang Medical Technology Business Overview
11.2.3 Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Introduction
11.2.4 Hangzhou Weiqiang Medical Technology Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.2.5 Hangzhou Weiqiang Medical Technology Recent Development
11.3 Suzhou Yinluo Medical Devices
11.3.1 Suzhou Yinluo Medical Devices Company Details
11.3.2 Suzhou Yinluo Medical Devices Business Overview
11.3.3 Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Introduction
11.3.4 Suzhou Yinluo Medical Devices Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.3.5 Suzhou Yinluo Medical Devices Recent Development
11.4 Zylox-Tonbridge Medical Technology
11.4.1 Zylox-Tonbridge Medical Technology Company Details
11.4.2 Zylox-Tonbridge Medical Technology Business Overview
11.4.3 Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Introduction
11.4.4 Zylox-Tonbridge Medical Technology Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.4.5 Zylox-Tonbridge Medical Technology Recent Development
11.5 Shanghai Ensheng Medical Technology
11.5.1 Shanghai Ensheng Medical Technology Company Details
11.5.2 Shanghai Ensheng Medical Technology Business Overview
11.5.3 Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Introduction
11.5.4 Shanghai Ensheng Medical Technology Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.5.5 Shanghai Ensheng Medical Technology Recent Development
11.6 Suzhou Tianhong Shengjie Medical Devices
11.6.1 Suzhou Tianhong Shengjie Medical Devices Company Details
11.6.2 Suzhou Tianhong Shengjie Medical Devices Business Overview
11.6.3 Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Introduction
11.6.4 Suzhou Tianhong Shengjie Medical Devices Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.6.5 Suzhou Tianhong Shengjie Medical Devices Recent Development
11.7 BD(Angiomed)
11.7.1 BD(Angiomed) Company Details
11.7.2 BD(Angiomed) Business Overview
11.7.3 BD(Angiomed) Chronic Venous Insufficiency Introduction
11.7.4 BD(Angiomed) Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.7.5 BD(Angiomed) Recent Development
11.8 Boston Scientific
11.8.1 Boston Scientific Company Details
11.8.2 Boston Scientific Business Overview
11.8.3 Boston Scientific Chronic Venous Insufficiency Introduction
11.8.4 Boston Scientific Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.8.5 Boston Scientific Recent Development
11.9 Cook Ireland
11.9.1 Cook Ireland Company Details
11.9.2 Cook Ireland Business Overview
11.9.3 Cook Ireland Chronic Venous Insufficiency Introduction
11.9.4 Cook Ireland Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.9.5 Cook Ireland Recent Development
11.10 Medtronic
11.10.1 Medtronic Company Details
11.10.2 Medtronic Business Overview
11.10.3 Medtronic Chronic Venous Insufficiency Introduction
11.10.4 Medtronic Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.10.5 Medtronic Recent Development
11.11 optimed Medizinische Instrumente
11.11.1 optimed Medizinische Instrumente Company Details
11.11.2 optimed Medizinische Instrumente Business Overview
11.11.3 optimed Medizinische Instrumente Chronic Venous Insufficiency Introduction
11.11.4 optimed Medizinische Instrumente Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.11.5 optimed Medizinische Instrumente Recent Development
11.12 Philips
11.12.1 Philips Company Details
11.12.2 Philips Business Overview
11.12.3 Philips Chronic Venous Insufficiency Introduction
11.12.4 Philips Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.12.5 Philips Recent Development
11.13 3M
11.13.1 3M Company Details
11.13.2 3M Business Overview
11.13.3 3M Chronic Venous Insufficiency Introduction
11.13.4 3M Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.13.5 3M Recent Development
11.14 Teva
11.14.1 Teva Company Details
11.14.2 Teva Business Overview
11.14.3 Teva Chronic Venous Insufficiency Introduction
11.14.4 Teva Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.14.5 Teva Recent Development
11.15 Mylan
11.15.1 Mylan Company Details
11.15.2 Mylan Business Overview
11.15.3 Mylan Chronic Venous Insufficiency Introduction
11.15.4 Mylan Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.15.5 Mylan Recent Development
11.16 Pfizer
11.16.1 Pfizer Company Details
11.16.2 Pfizer Business Overview
11.16.3 Pfizer Chronic Venous Insufficiency Introduction
11.16.4 Pfizer Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.16.5 Pfizer Recent Development
11.17 AbbVie
11.17.1 AbbVie Company Details
11.17.2 AbbVie Business Overview
11.17.3 AbbVie Chronic Venous Insufficiency Introduction
11.17.4 AbbVie Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.17.5 AbbVie Recent Development
11.18 Abbott
11.18.1 Abbott Company Details
11.18.2 Abbott Business Overview
11.18.3 Abbott Chronic Venous Insufficiency Introduction
11.18.4 Abbott Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.18.5 Abbott Recent Development
11.19 Allergan
11.19.1 Allergan Company Details
11.19.2 Allergan Business Overview
11.19.3 Allergan Chronic Venous Insufficiency Introduction
11.19.4 Allergan Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.19.5 Allergan Recent Development
11.20 Sun Pharma
11.20.1 Sun Pharma Company Details
11.20.2 Sun Pharma Business Overview
11.20.3 Sun Pharma Chronic Venous Insufficiency Introduction
11.20.4 Sun Pharma Revenue in Chronic Venous Insufficiency Business (2021–2026)
11.20.5 Sun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Shanghai Lanmai Medical Technology
Hangzhou Weiqiang Medical Technology
Suzhou Yinluo Medical Devices
Zylox-Tonbridge Medical Technology
Shanghai Ensheng Medical Technology
Suzhou Tianhong Shengjie Medical Devices
BD(Angiomed)
Boston Scientific
Cook Ireland
Medtronic Inc
OptiMed Medizinische Instrumente
Philips
3M
TEVA
Mylan NV
Pfizer Inc
AbbVie
Abbott
Allergan plc
Sun Pharma
List of Tables
 Table 1. Global Chronic Venous Insufficiency Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Medical Equipment and Consumables
 Table 3. Key Players of Drugs
 Table 4. Global Chronic Venous Insufficiency Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Global Chronic Venous Insufficiency Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 6. Global Chronic Venous Insufficiency Market Size by Region (US$ Million), 2021–2026
 Table 7. Global Chronic Venous Insufficiency Market Share by Region (2021–2026)
 Table 8. Global Chronic Venous Insufficiency Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 9. Global Chronic Venous Insufficiency Market Share by Region (2027–2032)
 Table 10. Chronic Venous Insufficiency Market Trends
 Table 11. Chronic Venous Insufficiency Market Drivers
 Table 12. Chronic Venous Insufficiency Market Challenges
 Table 13. Chronic Venous Insufficiency Market Restraints
 Table 14. Global Chronic Venous Insufficiency Revenue by Players (US$ Million), 2021–2026
 Table 15. Global Chronic Venous Insufficiency Market Share by Players (2021–2026)
 Table 16. Global Top Chronic Venous Insufficiency Players by Tier (Tier 1, Tier 2, and Tier 3), based on Chronic Venous Insufficiency Revenue, 2025
 Table 17. Ranking of Global Top Chronic Venous Insufficiency Companies by Revenue (US$ Million) in 2025
 Table 18. Global 5 Largest Players Market Share by Chronic Venous Insufficiency Revenue (CR5 and HHI), 2021–2026
 Table 19. Global Key Players of Chronic Venous Insufficiency, Headquarters and Area Served
 Table 20. Global Key Players of Chronic Venous Insufficiency, Products and Applications
 Table 21. Global Key Players of Chronic Venous Insufficiency, Date of General Availability (GA)
 Table 22. Mergers and Acquisitions, Expansion Plans
 Table 23. Global Chronic Venous Insufficiency Market Size by Type (US$ Million), 2021–2026
 Table 24. Global Chronic Venous Insufficiency Revenue Market Share by Type (2021–2026)
 Table 25. Global Chronic Venous Insufficiency Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 26. Global Chronic Venous Insufficiency Revenue Market Share by Type (2027–2032)
 Table 27. Global Chronic Venous Insufficiency Market Size by Application (US$ Million), 2021–2026
 Table 28. Global Chronic Venous Insufficiency Revenue Market Share by Application (2021–2026)
 Table 29. Global Chronic Venous Insufficiency Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 30. Global Chronic Venous Insufficiency Revenue Market Share by Application (2027–2032)
 Table 31. North America Chronic Venous Insufficiency Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 32. North America Chronic Venous Insufficiency Market Size by Country (US$ Million), 2021–2026
 Table 33. North America Chronic Venous Insufficiency Market Size by Country (US$ Million), 2027–2032
 Table 34. Europe Chronic Venous Insufficiency Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. Europe Chronic Venous Insufficiency Market Size by Country (US$ Million), 2021–2026
 Table 36. Europe Chronic Venous Insufficiency Market Size by Country (US$ Million), 2027–2032
 Table 37. Asia-Pacific Chronic Venous Insufficiency Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Asia-Pacific Chronic Venous Insufficiency Market Size by Region (US$ Million), 2021–2026
 Table 39. Asia-Pacific Chronic Venous Insufficiency Market Size by Region (US$ Million), 2027–2032
 Table 40. Latin America Chronic Venous Insufficiency Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Latin America Chronic Venous Insufficiency Market Size by Country (US$ Million), 2021–2026
 Table 42. Latin America Chronic Venous Insufficiency Market Size by Country (US$ Million), 2027–2032
 Table 43. Middle East & Africa Chronic Venous Insufficiency Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Middle East & Africa Chronic Venous Insufficiency Market Size by Country (US$ Million), 2021–2026
 Table 45. Middle East & Africa Chronic Venous Insufficiency Market Size by Country (US$ Million), 2027–2032
 Table 46. Shanghai Lanmai Medical Technology Company Details
 Table 47. Shanghai Lanmai Medical Technology Business Overview
 Table 48. Shanghai Lanmai Medical Technology Chronic Venous Insufficiency Product
 Table 49. Shanghai Lanmai Medical Technology Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 50. Shanghai Lanmai Medical Technology Recent Development
 Table 51. Hangzhou Weiqiang Medical Technology Company Details
 Table 52. Hangzhou Weiqiang Medical Technology Business Overview
 Table 53. Hangzhou Weiqiang Medical Technology Chronic Venous Insufficiency Product
 Table 54. Hangzhou Weiqiang Medical Technology Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 55. Hangzhou Weiqiang Medical Technology Recent Development
 Table 56. Suzhou Yinluo Medical Devices Company Details
 Table 57. Suzhou Yinluo Medical Devices Business Overview
 Table 58. Suzhou Yinluo Medical Devices Chronic Venous Insufficiency Product
 Table 59. Suzhou Yinluo Medical Devices Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 60. Suzhou Yinluo Medical Devices Recent Development
 Table 61. Zylox-Tonbridge Medical Technology Company Details
 Table 62. Zylox-Tonbridge Medical Technology Business Overview
 Table 63. Zylox-Tonbridge Medical Technology Chronic Venous Insufficiency Product
 Table 64. Zylox-Tonbridge Medical Technology Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 65. Zylox-Tonbridge Medical Technology Recent Development
 Table 66. Shanghai Ensheng Medical Technology Company Details
 Table 67. Shanghai Ensheng Medical Technology Business Overview
 Table 68. Shanghai Ensheng Medical Technology Chronic Venous Insufficiency Product
 Table 69. Shanghai Ensheng Medical Technology Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 70. Shanghai Ensheng Medical Technology Recent Development
 Table 71. Suzhou Tianhong Shengjie Medical Devices Company Details
 Table 72. Suzhou Tianhong Shengjie Medical Devices Business Overview
 Table 73. Suzhou Tianhong Shengjie Medical Devices Chronic Venous Insufficiency Product
 Table 74. Suzhou Tianhong Shengjie Medical Devices Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 75. Suzhou Tianhong Shengjie Medical Devices Recent Development
 Table 76. BD(Angiomed) Company Details
 Table 77. BD(Angiomed) Business Overview
 Table 78. BD(Angiomed) Chronic Venous Insufficiency Product
 Table 79. BD(Angiomed) Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 80. BD(Angiomed) Recent Development
 Table 81. Boston Scientific Company Details
 Table 82. Boston Scientific Business Overview
 Table 83. Boston Scientific Chronic Venous Insufficiency Product
 Table 84. Boston Scientific Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 85. Boston Scientific Recent Development
 Table 86. Cook Ireland Company Details
 Table 87. Cook Ireland Business Overview
 Table 88. Cook Ireland Chronic Venous Insufficiency Product
 Table 89. Cook Ireland Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 90. Cook Ireland Recent Development
 Table 91. Medtronic Company Details
 Table 92. Medtronic Business Overview
 Table 93. Medtronic Chronic Venous Insufficiency Product
 Table 94. Medtronic Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 95. Medtronic Recent Development
 Table 96. optimed Medizinische Instrumente Company Details
 Table 97. optimed Medizinische Instrumente Business Overview
 Table 98. optimed Medizinische Instrumente Chronic Venous Insufficiency Product
 Table 99. optimed Medizinische Instrumente Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 100. optimed Medizinische Instrumente Recent Development
 Table 101. Philips Company Details
 Table 102. Philips Business Overview
 Table 103. Philips Chronic Venous Insufficiency Product
 Table 104. Philips Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 105. Philips Recent Development
 Table 106. 3M Company Details
 Table 107. 3M Business Overview
 Table 108. 3M Chronic Venous Insufficiency Product
 Table 109. 3M Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 110. 3M Recent Development
 Table 111. Teva Company Details
 Table 112. Teva Business Overview
 Table 113. Teva Chronic Venous Insufficiency Product
 Table 114. Teva Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 115. Teva Recent Development
 Table 116. Mylan Company Details
 Table 117. Mylan Business Overview
 Table 118. Mylan Chronic Venous Insufficiency Product
 Table 119. Mylan Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 120. Mylan Recent Development
 Table 121. Pfizer Company Details
 Table 122. Pfizer Business Overview
 Table 123. Pfizer Chronic Venous Insufficiency Product
 Table 124. Pfizer Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 125. Pfizer Recent Development
 Table 126. AbbVie Company Details
 Table 127. AbbVie Business Overview
 Table 128. AbbVie Chronic Venous Insufficiency Product
 Table 129. AbbVie Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 130. AbbVie Recent Development
 Table 131. Abbott Company Details
 Table 132. Abbott Business Overview
 Table 133. Abbott Chronic Venous Insufficiency Product
 Table 134. Abbott Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 135. Abbott Recent Development
 Table 136. Allergan Company Details
 Table 137. Allergan Business Overview
 Table 138. Allergan Chronic Venous Insufficiency Product
 Table 139. Allergan Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 140. Allergan Recent Development
 Table 141. Sun Pharma Company Details
 Table 142. Sun Pharma Business Overview
 Table 143. Sun Pharma Chronic Venous Insufficiency Product
 Table 144. Sun Pharma Revenue in Chronic Venous Insufficiency Business (US$ Million), 2021–2026
 Table 145. Sun Pharma Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Chronic Venous Insufficiency Picture
 Figure 2. Global Chronic Venous Insufficiency Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Chronic Venous Insufficiency Market Share by Type: 2025 vs 2032
 Figure 4. Medical Equipment and Consumables Features
 Figure 5. Drugs Features
 Figure 6. Global Chronic Venous Insufficiency Market Size by Application (US$ Million), 2021–2032
 Figure 7. Global Chronic Venous Insufficiency Market Share by Application: 2025 vs 2032
 Figure 8. Hospital Case Studies
 Figure 9. Clinic Case Studies
 Figure 10. Other Case Studies
 Figure 11. Chronic Venous Insufficiency Report Years Considered
 Figure 12. Global Chronic Venous Insufficiency Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 13. Global Chronic Venous Insufficiency Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Chronic Venous Insufficiency Market Share by Region: 2025 vs 2032
 Figure 15. Global Chronic Venous Insufficiency Market Share by Players in 2025
 Figure 16. Global Chronic Venous Insufficiency Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 17. The Top 10 and 5 Players Market Share by Chronic Venous Insufficiency Revenue in 2025
 Figure 18. North America Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 19. North America Chronic Venous Insufficiency Market Share by Country (2021–2032)
 Figure 20. United States Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 21. Canada Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Europe Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe Chronic Venous Insufficiency Market Share by Country (2021–2032)
 Figure 24. Germany Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. France Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. U.K. Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Italy Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Russia Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Ireland Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Asia-Pacific Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific Chronic Venous Insufficiency Market Share by Region (2021–2032)
 Figure 32. China Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Japan Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. South Korea Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Southeast Asia Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. India Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Australia & New Zealand Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Latin America Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America Chronic Venous Insufficiency Market Share by Country (2021–2032)
 Figure 40. Mexico Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Brazil Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Middle East & Africa Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa Chronic Venous Insufficiency Market Share by Country (2021–2032)
 Figure 44. Israel Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Saudi Arabia Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. UAE Chronic Venous Insufficiency Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Shanghai Lanmai Medical Technology Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 48. Hangzhou Weiqiang Medical Technology Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 49. Suzhou Yinluo Medical Devices Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 50. Zylox-Tonbridge Medical Technology Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 51. Shanghai Ensheng Medical Technology Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 52. Suzhou Tianhong Shengjie Medical Devices Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 53. BD(Angiomed) Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 54. Boston Scientific Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 55. Cook Ireland Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 56. Medtronic Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 57. optimed Medizinische Instrumente Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 58. Philips Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 59. 3M Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 60. Teva Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 61. Mylan Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 62. Pfizer Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 63. AbbVie Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 64. Abbott Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 65. Allergan Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 66. Sun Pharma Revenue Growth Rate in Chronic Venous Insufficiency Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions